nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—HTR1D—meninx—sarcoma	0.0875	0.216	CbGeAlD
Atomoxetine—HTR1B—dura mater—sarcoma	0.0832	0.205	CbGeAlD
Atomoxetine—HTR1D—dura mater—sarcoma	0.0806	0.199	CbGeAlD
Atomoxetine—HTR2A—pulmonary artery—sarcoma	0.0171	0.0421	CbGeAlD
Atomoxetine—NPY1R—myometrium—sarcoma	0.015	0.037	CbGeAlD
Atomoxetine—NPY1R—seminal vesicle—sarcoma	0.0135	0.0334	CbGeAlD
Atomoxetine—NPY1R—hematopoietic system—sarcoma	0.0129	0.0318	CbGeAlD
Atomoxetine—HTR2A—hindlimb—sarcoma	0.0103	0.0255	CbGeAlD
Atomoxetine—HTR2A—appendage—sarcoma	0.00886	0.0219	CbGeAlD
Atomoxetine—CYP3A4—Thiotepa—sarcoma	0.00811	0.404	CbGbCtD
Atomoxetine—NPY1R—testis—sarcoma	0.00706	0.0174	CbGeAlD
Atomoxetine—Pseudoephedrine—IL2—sarcoma	0.00697	1	CrCbGaD
Atomoxetine—NPY1R—liver—sarcoma	0.00667	0.0164	CbGeAlD
Atomoxetine—SLC6A3—hematopoietic system—sarcoma	0.00542	0.0134	CbGeAlD
Atomoxetine—HTR2A—endothelium—sarcoma	0.00535	0.0132	CbGeAlD
Atomoxetine—NPY1R—lymph node—sarcoma	0.00512	0.0126	CbGeAlD
Atomoxetine—HTR1D—connective tissue—sarcoma	0.00509	0.0126	CbGeAlD
Atomoxetine—SLC6A4—hematopoietic system—sarcoma	0.00496	0.0122	CbGeAlD
Atomoxetine—CYP2C19—hematopoietic system—sarcoma	0.00411	0.0101	CbGeAlD
Atomoxetine—CYP3A4—Mitoxantrone—sarcoma	0.00349	0.174	CbGbCtD
Atomoxetine—SLC6A3—testis—sarcoma	0.00297	0.00732	CbGeAlD
Atomoxetine—HTR2A—embryo—sarcoma	0.00294	0.00726	CbGeAlD
Atomoxetine—HTR2A—hematopoietic system—sarcoma	0.00263	0.00648	CbGeAlD
Atomoxetine—HTR2A—connective tissue—sarcoma	0.00253	0.00624	CbGeAlD
Atomoxetine—CYP3A4—hematopoietic system—sarcoma	0.00243	0.006	CbGeAlD
Atomoxetine—CYP3A4—Vincristine—sarcoma	0.0024	0.12	CbGbCtD
Atomoxetine—SLC6A2—testis—sarcoma	0.0024	0.00591	CbGeAlD
Atomoxetine—CYP2D6—hematopoietic system—sarcoma	0.00239	0.0059	CbGeAlD
Atomoxetine—CYP2D6—Doxorubicin—sarcoma	0.00236	0.118	CbGbCtD
Atomoxetine—HTR2A—smooth muscle tissue—sarcoma	0.00231	0.00571	CbGeAlD
Atomoxetine—CYP3A4—Etoposide—sarcoma	0.0022	0.11	CbGbCtD
Atomoxetine—CYP2C19—liver—sarcoma	0.00213	0.00526	CbGeAlD
Atomoxetine—HTR2A—tendon—sarcoma	0.00174	0.00429	CbGeAlD
Atomoxetine—SLC6A2—lymph node—sarcoma	0.00174	0.00428	CbGeAlD
Atomoxetine—CYP3A4—Doxorubicin—sarcoma	0.0015	0.0748	CbGbCtD
Atomoxetine—Lethargy—Epirubicin—sarcoma	0.00147	0.0026	CcSEcCtD
Atomoxetine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00147	0.00259	CcSEcCtD
Atomoxetine—Feeling abnormal—Thiotepa—sarcoma	0.00145	0.00256	CcSEcCtD
Atomoxetine—Anorexia—Mitoxantrone—sarcoma	0.00145	0.00256	CcSEcCtD
Atomoxetine—Feeling abnormal—Dactinomycin—sarcoma	0.00144	0.00254	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Thiotepa—sarcoma	0.00144	0.00254	CcSEcCtD
Atomoxetine—HTR2A—testis—sarcoma	0.00144	0.00355	CbGeAlD
Atomoxetine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00143	0.00252	CcSEcCtD
Atomoxetine—Hot flush—Doxorubicin—sarcoma	0.00143	0.00252	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Vincristine—sarcoma	0.00142	0.00251	CcSEcCtD
Atomoxetine—Affect lability—Epirubicin—sarcoma	0.00142	0.00251	CcSEcCtD
Atomoxetine—Menopausal symptoms—Doxorubicin—sarcoma	0.00142	0.0025	CcSEcCtD
Atomoxetine—Insomnia—Vincristine—sarcoma	0.00141	0.00249	CcSEcCtD
Atomoxetine—Paraesthesia—Vincristine—sarcoma	0.0014	0.00247	CcSEcCtD
Atomoxetine—Urticaria—Thiotepa—sarcoma	0.0014	0.00247	CcSEcCtD
Atomoxetine—Vertigo—Etoposide—sarcoma	0.00139	0.00246	CcSEcCtD
Atomoxetine—Body temperature increased—Thiotepa—sarcoma	0.00139	0.00246	CcSEcCtD
Atomoxetine—Abdominal pain—Thiotepa—sarcoma	0.00139	0.00246	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00139	0.00244	CcSEcCtD
Atomoxetine—Abdominal pain—Dactinomycin—sarcoma	0.00138	0.00244	CcSEcCtD
Atomoxetine—Body temperature increased—Dactinomycin—sarcoma	0.00138	0.00244	CcSEcCtD
Atomoxetine—Mood swings—Epirubicin—sarcoma	0.00137	0.00241	CcSEcCtD
Atomoxetine—Paraesthesia—Mitoxantrone—sarcoma	0.00137	0.00241	CcSEcCtD
Atomoxetine—Loss of consciousness—Etoposide—sarcoma	0.00136	0.0024	CcSEcCtD
Atomoxetine—Lethargy—Doxorubicin—sarcoma	0.00136	0.0024	CcSEcCtD
Atomoxetine—HTR2A—liver—sarcoma	0.00136	0.00336	CbGeAlD
Atomoxetine—Decreased appetite—Vincristine—sarcoma	0.00136	0.00239	CcSEcCtD
Atomoxetine—Cough—Etoposide—sarcoma	0.00135	0.00239	CcSEcCtD
Atomoxetine—Somnolence—Mitoxantrone—sarcoma	0.00135	0.00239	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Vincristine—sarcoma	0.00135	0.00238	CcSEcCtD
Atomoxetine—Fatigue—Vincristine—sarcoma	0.00135	0.00238	CcSEcCtD
Atomoxetine—Convulsion—Etoposide—sarcoma	0.00134	0.00237	CcSEcCtD
Atomoxetine—Dyspepsia—Mitoxantrone—sarcoma	0.00134	0.00236	CcSEcCtD
Atomoxetine—Pain—Vincristine—sarcoma	0.00134	0.00236	CcSEcCtD
Atomoxetine—Constipation—Vincristine—sarcoma	0.00134	0.00236	CcSEcCtD
Atomoxetine—Decreased appetite—Mitoxantrone—sarcoma	0.00132	0.00233	CcSEcCtD
Atomoxetine—Chest pain—Etoposide—sarcoma	0.00132	0.00233	CcSEcCtD
Atomoxetine—Abdominal pain upper—Epirubicin—sarcoma	0.00132	0.00232	CcSEcCtD
Atomoxetine—Affect lability—Doxorubicin—sarcoma	0.00132	0.00232	CcSEcCtD
Atomoxetine—Fatigue—Mitoxantrone—sarcoma	0.00131	0.00231	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00131	0.00231	CcSEcCtD
Atomoxetine—CYP2D6—testis—sarcoma	0.00131	0.00323	CbGeAlD
Atomoxetine—Breast disorder—Epirubicin—sarcoma	0.00131	0.0023	CcSEcCtD
Atomoxetine—Pain—Mitoxantrone—sarcoma	0.0013	0.00229	CcSEcCtD
Atomoxetine—Constipation—Mitoxantrone—sarcoma	0.0013	0.00229	CcSEcCtD
Atomoxetine—Nasopharyngitis—Epirubicin—sarcoma	0.00129	0.00228	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Vincristine—sarcoma	0.00128	0.00225	CcSEcCtD
Atomoxetine—Mood swings—Doxorubicin—sarcoma	0.00127	0.00223	CcSEcCtD
Atomoxetine—Asthenia—Thiotepa—sarcoma	0.00126	0.00223	CcSEcCtD
Atomoxetine—CYP3A4—liver—sarcoma	0.00126	0.00311	CbGeAlD
Atomoxetine—Infection—Etoposide—sarcoma	0.00126	0.00222	CcSEcCtD
Atomoxetine—Asthenia—Dactinomycin—sarcoma	0.00126	0.00221	CcSEcCtD
Atomoxetine—Feeling abnormal—Mitoxantrone—sarcoma	0.00125	0.00221	CcSEcCtD
Atomoxetine—Influenza—Epirubicin—sarcoma	0.00125	0.0022	CcSEcCtD
Atomoxetine—Pruritus—Thiotepa—sarcoma	0.00125	0.0022	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00124	0.00219	CcSEcCtD
Atomoxetine—CYP2D6—liver—sarcoma	0.00124	0.00306	CbGeAlD
Atomoxetine—Tachycardia—Etoposide—sarcoma	0.00124	0.00218	CcSEcCtD
Atomoxetine—Body temperature increased—Vincristine—sarcoma	0.00124	0.00218	CcSEcCtD
Atomoxetine—Abdominal pain—Vincristine—sarcoma	0.00124	0.00218	CcSEcCtD
Atomoxetine—Skin disorder—Etoposide—sarcoma	0.00123	0.00217	CcSEcCtD
Atomoxetine—Hyperhidrosis—Etoposide—sarcoma	0.00122	0.00216	CcSEcCtD
Atomoxetine—Abdominal pain upper—Doxorubicin—sarcoma	0.00122	0.00215	CcSEcCtD
Atomoxetine—Urticaria—Mitoxantrone—sarcoma	0.00121	0.00213	CcSEcCtD
Atomoxetine—Breast disorder—Doxorubicin—sarcoma	0.00121	0.00213	CcSEcCtD
Atomoxetine—Anorexia—Etoposide—sarcoma	0.00121	0.00213	CcSEcCtD
Atomoxetine—Diarrhoea—Thiotepa—sarcoma	0.00121	0.00213	CcSEcCtD
Atomoxetine—Abdominal pain—Mitoxantrone—sarcoma	0.0012	0.00212	CcSEcCtD
Atomoxetine—Body temperature increased—Mitoxantrone—sarcoma	0.0012	0.00212	CcSEcCtD
Atomoxetine—Diarrhoea—Dactinomycin—sarcoma	0.0012	0.00211	CcSEcCtD
Atomoxetine—Nasopharyngitis—Doxorubicin—sarcoma	0.00119	0.00211	CcSEcCtD
Atomoxetine—Dysuria—Epirubicin—sarcoma	0.00117	0.00206	CcSEcCtD
Atomoxetine—Dizziness—Thiotepa—sarcoma	0.00117	0.00205	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Epirubicin—sarcoma	0.00116	0.00204	CcSEcCtD
Atomoxetine—Influenza—Doxorubicin—sarcoma	0.00115	0.00204	CcSEcCtD
Atomoxetine—Pollakiuria—Epirubicin—sarcoma	0.00115	0.00203	CcSEcCtD
Atomoxetine—Paraesthesia—Etoposide—sarcoma	0.00114	0.002	CcSEcCtD
Atomoxetine—Weight decreased—Epirubicin—sarcoma	0.00113	0.00199	CcSEcCtD
Atomoxetine—Somnolence—Etoposide—sarcoma	0.00113	0.00198	CcSEcCtD
Atomoxetine—Asthenia—Vincristine—sarcoma	0.00112	0.00198	CcSEcCtD
Atomoxetine—Vomiting—Thiotepa—sarcoma	0.00112	0.00198	CcSEcCtD
Atomoxetine—Infestation—Epirubicin—sarcoma	0.00111	0.00196	CcSEcCtD
Atomoxetine—Infestation NOS—Epirubicin—sarcoma	0.00111	0.00196	CcSEcCtD
Atomoxetine—Vomiting—Dactinomycin—sarcoma	0.00111	0.00196	CcSEcCtD
Atomoxetine—Rash—Thiotepa—sarcoma	0.00111	0.00196	CcSEcCtD
Atomoxetine—Dermatitis—Thiotepa—sarcoma	0.00111	0.00196	CcSEcCtD
Atomoxetine—Headache—Thiotepa—sarcoma	0.0011	0.00195	CcSEcCtD
Atomoxetine—Rash—Dactinomycin—sarcoma	0.0011	0.00194	CcSEcCtD
Atomoxetine—Decreased appetite—Etoposide—sarcoma	0.0011	0.00194	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Etoposide—sarcoma	0.00109	0.00193	CcSEcCtD
Atomoxetine—Asthenia—Mitoxantrone—sarcoma	0.00109	0.00193	CcSEcCtD
Atomoxetine—Fatigue—Etoposide—sarcoma	0.00109	0.00192	CcSEcCtD
Atomoxetine—Constipation—Etoposide—sarcoma	0.00108	0.00191	CcSEcCtD
Atomoxetine—Pain—Etoposide—sarcoma	0.00108	0.00191	CcSEcCtD
Atomoxetine—Conjunctivitis—Epirubicin—sarcoma	0.00108	0.00191	CcSEcCtD
Atomoxetine—Dysuria—Doxorubicin—sarcoma	0.00108	0.0019	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00107	0.00189	CcSEcCtD
Atomoxetine—Diarrhoea—Vincristine—sarcoma	0.00107	0.00189	CcSEcCtD
Atomoxetine—Pollakiuria—Doxorubicin—sarcoma	0.00107	0.00188	CcSEcCtD
Atomoxetine—Nausea—Thiotepa—sarcoma	0.00105	0.00185	CcSEcCtD
Atomoxetine—Weight decreased—Doxorubicin—sarcoma	0.00104	0.00184	CcSEcCtD
Atomoxetine—Sinusitis—Epirubicin—sarcoma	0.00104	0.00184	CcSEcCtD
Atomoxetine—Feeling abnormal—Etoposide—sarcoma	0.00104	0.00184	CcSEcCtD
Atomoxetine—Diarrhoea—Mitoxantrone—sarcoma	0.00104	0.00184	CcSEcCtD
Atomoxetine—Nausea—Dactinomycin—sarcoma	0.00104	0.00183	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Etoposide—sarcoma	0.00104	0.00182	CcSEcCtD
Atomoxetine—Dizziness—Vincristine—sarcoma	0.00103	0.00182	CcSEcCtD
Atomoxetine—Infestation NOS—Doxorubicin—sarcoma	0.00103	0.00181	CcSEcCtD
Atomoxetine—Infestation—Doxorubicin—sarcoma	0.00103	0.00181	CcSEcCtD
Atomoxetine—Urticaria—Etoposide—sarcoma	0.00101	0.00177	CcSEcCtD
Atomoxetine—Abdominal pain—Etoposide—sarcoma	0.001	0.00176	CcSEcCtD
Atomoxetine—Body temperature increased—Etoposide—sarcoma	0.001	0.00176	CcSEcCtD
Atomoxetine—Conjunctivitis—Doxorubicin—sarcoma	0.001	0.00176	CcSEcCtD
Atomoxetine—Hypoaesthesia—Epirubicin—sarcoma	0.000994	0.00175	CcSEcCtD
Atomoxetine—Vomiting—Vincristine—sarcoma	0.000994	0.00175	CcSEcCtD
Atomoxetine—Urinary tract disorder—Epirubicin—sarcoma	0.000987	0.00174	CcSEcCtD
Atomoxetine—Rash—Vincristine—sarcoma	0.000986	0.00174	CcSEcCtD
Atomoxetine—Dermatitis—Vincristine—sarcoma	0.000985	0.00174	CcSEcCtD
Atomoxetine—Urethral disorder—Epirubicin—sarcoma	0.000979	0.00173	CcSEcCtD
Atomoxetine—Headache—Vincristine—sarcoma	0.000979	0.00173	CcSEcCtD
Atomoxetine—Vomiting—Mitoxantrone—sarcoma	0.000968	0.00171	CcSEcCtD
Atomoxetine—Sinusitis—Doxorubicin—sarcoma	0.000966	0.0017	CcSEcCtD
Atomoxetine—Rash—Mitoxantrone—sarcoma	0.00096	0.00169	CcSEcCtD
Atomoxetine—Dermatitis—Mitoxantrone—sarcoma	0.000959	0.00169	CcSEcCtD
Atomoxetine—Headache—Mitoxantrone—sarcoma	0.000954	0.00168	CcSEcCtD
Atomoxetine—Nausea—Vincristine—sarcoma	0.000929	0.00164	CcSEcCtD
Atomoxetine—Flushing—Epirubicin—sarcoma	0.000927	0.00163	CcSEcCtD
Atomoxetine—Cardiac disorder—Epirubicin—sarcoma	0.000927	0.00163	CcSEcCtD
Atomoxetine—Hypoaesthesia—Doxorubicin—sarcoma	0.00092	0.00162	CcSEcCtD
Atomoxetine—Urinary tract disorder—Doxorubicin—sarcoma	0.000913	0.00161	CcSEcCtD
Atomoxetine—Asthenia—Etoposide—sarcoma	0.000909	0.0016	CcSEcCtD
Atomoxetine—Angiopathy—Epirubicin—sarcoma	0.000906	0.0016	CcSEcCtD
Atomoxetine—Urethral disorder—Doxorubicin—sarcoma	0.000906	0.0016	CcSEcCtD
Atomoxetine—Nausea—Mitoxantrone—sarcoma	0.000904	0.00159	CcSEcCtD
Atomoxetine—Mediastinal disorder—Epirubicin—sarcoma	0.0009	0.00159	CcSEcCtD
Atomoxetine—Chills—Epirubicin—sarcoma	0.000896	0.00158	CcSEcCtD
Atomoxetine—Pruritus—Etoposide—sarcoma	0.000896	0.00158	CcSEcCtD
Atomoxetine—Mental disorder—Epirubicin—sarcoma	0.000875	0.00154	CcSEcCtD
Atomoxetine—Malnutrition—Epirubicin—sarcoma	0.00087	0.00153	CcSEcCtD
Atomoxetine—Diarrhoea—Etoposide—sarcoma	0.000866	0.00153	CcSEcCtD
Atomoxetine—Flushing—Doxorubicin—sarcoma	0.000858	0.00151	CcSEcCtD
Atomoxetine—Cardiac disorder—Doxorubicin—sarcoma	0.000858	0.00151	CcSEcCtD
Atomoxetine—Flatulence—Epirubicin—sarcoma	0.000857	0.00151	CcSEcCtD
Atomoxetine—Tension—Epirubicin—sarcoma	0.000853	0.0015	CcSEcCtD
Atomoxetine—Dysgeusia—Epirubicin—sarcoma	0.000852	0.0015	CcSEcCtD
Atomoxetine—Nervousness—Epirubicin—sarcoma	0.000845	0.00149	CcSEcCtD
Atomoxetine—Back pain—Epirubicin—sarcoma	0.000841	0.00148	CcSEcCtD
Atomoxetine—Angiopathy—Doxorubicin—sarcoma	0.000839	0.00148	CcSEcCtD
Atomoxetine—Dizziness—Etoposide—sarcoma	0.000837	0.00148	CcSEcCtD
Atomoxetine—Muscle spasms—Epirubicin—sarcoma	0.000836	0.00147	CcSEcCtD
Atomoxetine—Mediastinal disorder—Doxorubicin—sarcoma	0.000833	0.00147	CcSEcCtD
Atomoxetine—Chills—Doxorubicin—sarcoma	0.000829	0.00146	CcSEcCtD
Atomoxetine—Vision blurred—Epirubicin—sarcoma	0.00082	0.00144	CcSEcCtD
Atomoxetine—Mental disorder—Doxorubicin—sarcoma	0.00081	0.00143	CcSEcCtD
Atomoxetine—Vomiting—Etoposide—sarcoma	0.000805	0.00142	CcSEcCtD
Atomoxetine—Malnutrition—Doxorubicin—sarcoma	0.000805	0.00142	CcSEcCtD
Atomoxetine—Agitation—Epirubicin—sarcoma	0.000799	0.00141	CcSEcCtD
Atomoxetine—Rash—Etoposide—sarcoma	0.000798	0.00141	CcSEcCtD
Atomoxetine—Dermatitis—Etoposide—sarcoma	0.000798	0.00141	CcSEcCtD
Atomoxetine—Headache—Etoposide—sarcoma	0.000793	0.0014	CcSEcCtD
Atomoxetine—Flatulence—Doxorubicin—sarcoma	0.000793	0.0014	CcSEcCtD
Atomoxetine—Tension—Doxorubicin—sarcoma	0.00079	0.00139	CcSEcCtD
Atomoxetine—Dysgeusia—Doxorubicin—sarcoma	0.000788	0.00139	CcSEcCtD
Atomoxetine—Nervousness—Doxorubicin—sarcoma	0.000782	0.00138	CcSEcCtD
Atomoxetine—Vertigo—Epirubicin—sarcoma	0.000781	0.00138	CcSEcCtD
Atomoxetine—Syncope—Epirubicin—sarcoma	0.00078	0.00137	CcSEcCtD
Atomoxetine—Back pain—Doxorubicin—sarcoma	0.000778	0.00137	CcSEcCtD
Atomoxetine—Muscle spasms—Doxorubicin—sarcoma	0.000774	0.00136	CcSEcCtD
Atomoxetine—Palpitations—Epirubicin—sarcoma	0.000769	0.00135	CcSEcCtD
Atomoxetine—Loss of consciousness—Epirubicin—sarcoma	0.000764	0.00135	CcSEcCtD
Atomoxetine—Cough—Epirubicin—sarcoma	0.000759	0.00134	CcSEcCtD
Atomoxetine—Vision blurred—Doxorubicin—sarcoma	0.000758	0.00134	CcSEcCtD
Atomoxetine—Convulsion—Epirubicin—sarcoma	0.000754	0.00133	CcSEcCtD
Atomoxetine—Nausea—Etoposide—sarcoma	0.000752	0.00133	CcSEcCtD
Atomoxetine—Chest pain—Epirubicin—sarcoma	0.00074	0.0013	CcSEcCtD
Atomoxetine—Myalgia—Epirubicin—sarcoma	0.00074	0.0013	CcSEcCtD
Atomoxetine—Arthralgia—Epirubicin—sarcoma	0.00074	0.0013	CcSEcCtD
Atomoxetine—Agitation—Doxorubicin—sarcoma	0.00074	0.0013	CcSEcCtD
Atomoxetine—Anxiety—Epirubicin—sarcoma	0.000738	0.0013	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000735	0.0013	CcSEcCtD
Atomoxetine—Dry mouth—Epirubicin—sarcoma	0.000724	0.00128	CcSEcCtD
Atomoxetine—Vertigo—Doxorubicin—sarcoma	0.000723	0.00127	CcSEcCtD
Atomoxetine—Syncope—Doxorubicin—sarcoma	0.000722	0.00127	CcSEcCtD
Atomoxetine—Palpitations—Doxorubicin—sarcoma	0.000711	0.00125	CcSEcCtD
Atomoxetine—Loss of consciousness—Doxorubicin—sarcoma	0.000707	0.00125	CcSEcCtD
Atomoxetine—Infection—Epirubicin—sarcoma	0.000705	0.00124	CcSEcCtD
Atomoxetine—Cough—Doxorubicin—sarcoma	0.000702	0.00124	CcSEcCtD
Atomoxetine—Shock—Epirubicin—sarcoma	0.000698	0.00123	CcSEcCtD
Atomoxetine—Convulsion—Doxorubicin—sarcoma	0.000697	0.00123	CcSEcCtD
Atomoxetine—Nervous system disorder—Epirubicin—sarcoma	0.000696	0.00123	CcSEcCtD
Atomoxetine—Tachycardia—Epirubicin—sarcoma	0.000693	0.00122	CcSEcCtD
Atomoxetine—Skin disorder—Epirubicin—sarcoma	0.000689	0.00122	CcSEcCtD
Atomoxetine—Hyperhidrosis—Epirubicin—sarcoma	0.000686	0.00121	CcSEcCtD
Atomoxetine—Arthralgia—Doxorubicin—sarcoma	0.000685	0.00121	CcSEcCtD
Atomoxetine—Myalgia—Doxorubicin—sarcoma	0.000685	0.00121	CcSEcCtD
Atomoxetine—Chest pain—Doxorubicin—sarcoma	0.000685	0.00121	CcSEcCtD
Atomoxetine—Anxiety—Doxorubicin—sarcoma	0.000683	0.0012	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00068	0.0012	CcSEcCtD
Atomoxetine—Anorexia—Epirubicin—sarcoma	0.000677	0.00119	CcSEcCtD
Atomoxetine—Dry mouth—Doxorubicin—sarcoma	0.00067	0.00118	CcSEcCtD
Atomoxetine—Infection—Doxorubicin—sarcoma	0.000652	0.00115	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000647	0.00114	CcSEcCtD
Atomoxetine—Shock—Doxorubicin—sarcoma	0.000646	0.00114	CcSEcCtD
Atomoxetine—Nervous system disorder—Doxorubicin—sarcoma	0.000644	0.00114	CcSEcCtD
Atomoxetine—Insomnia—Epirubicin—sarcoma	0.000642	0.00113	CcSEcCtD
Atomoxetine—Tachycardia—Doxorubicin—sarcoma	0.000641	0.00113	CcSEcCtD
Atomoxetine—Skin disorder—Doxorubicin—sarcoma	0.000638	0.00112	CcSEcCtD
Atomoxetine—Paraesthesia—Epirubicin—sarcoma	0.000637	0.00112	CcSEcCtD
Atomoxetine—Hyperhidrosis—Doxorubicin—sarcoma	0.000635	0.00112	CcSEcCtD
Atomoxetine—Somnolence—Epirubicin—sarcoma	0.000631	0.00111	CcSEcCtD
Atomoxetine—Anorexia—Doxorubicin—sarcoma	0.000626	0.0011	CcSEcCtD
Atomoxetine—Dyspepsia—Epirubicin—sarcoma	0.000625	0.0011	CcSEcCtD
Atomoxetine—Decreased appetite—Epirubicin—sarcoma	0.000617	0.00109	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000613	0.00108	CcSEcCtD
Atomoxetine—Fatigue—Epirubicin—sarcoma	0.000612	0.00108	CcSEcCtD
Atomoxetine—Pain—Epirubicin—sarcoma	0.000607	0.00107	CcSEcCtD
Atomoxetine—Constipation—Epirubicin—sarcoma	0.000607	0.00107	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000598	0.00105	CcSEcCtD
Atomoxetine—Insomnia—Doxorubicin—sarcoma	0.000594	0.00105	CcSEcCtD
Atomoxetine—Paraesthesia—Doxorubicin—sarcoma	0.00059	0.00104	CcSEcCtD
Atomoxetine—Feeling abnormal—Epirubicin—sarcoma	0.000585	0.00103	CcSEcCtD
Atomoxetine—Somnolence—Doxorubicin—sarcoma	0.000584	0.00103	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Epirubicin—sarcoma	0.00058	0.00102	CcSEcCtD
Atomoxetine—Dyspepsia—Doxorubicin—sarcoma	0.000578	0.00102	CcSEcCtD
Atomoxetine—Decreased appetite—Doxorubicin—sarcoma	0.000571	0.00101	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000567	0.000999	CcSEcCtD
Atomoxetine—Fatigue—Doxorubicin—sarcoma	0.000566	0.000998	CcSEcCtD
Atomoxetine—Urticaria—Epirubicin—sarcoma	0.000564	0.000994	CcSEcCtD
Atomoxetine—Pain—Doxorubicin—sarcoma	0.000562	0.00099	CcSEcCtD
Atomoxetine—Constipation—Doxorubicin—sarcoma	0.000562	0.00099	CcSEcCtD
Atomoxetine—Body temperature increased—Epirubicin—sarcoma	0.000561	0.000989	CcSEcCtD
Atomoxetine—Abdominal pain—Epirubicin—sarcoma	0.000561	0.000989	CcSEcCtD
Atomoxetine—Feeling abnormal—Doxorubicin—sarcoma	0.000541	0.000954	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000537	0.000947	CcSEcCtD
Atomoxetine—Urticaria—Doxorubicin—sarcoma	0.000522	0.00092	CcSEcCtD
Atomoxetine—Abdominal pain—Doxorubicin—sarcoma	0.000519	0.000915	CcSEcCtD
Atomoxetine—Body temperature increased—Doxorubicin—sarcoma	0.000519	0.000915	CcSEcCtD
Atomoxetine—Asthenia—Epirubicin—sarcoma	0.000509	0.000898	CcSEcCtD
Atomoxetine—Pruritus—Epirubicin—sarcoma	0.000502	0.000885	CcSEcCtD
Atomoxetine—Diarrhoea—Epirubicin—sarcoma	0.000486	0.000856	CcSEcCtD
Atomoxetine—Asthenia—Doxorubicin—sarcoma	0.000471	0.00083	CcSEcCtD
Atomoxetine—Dizziness—Epirubicin—sarcoma	0.000469	0.000827	CcSEcCtD
Atomoxetine—Pruritus—Doxorubicin—sarcoma	0.000465	0.000819	CcSEcCtD
Atomoxetine—Vomiting—Epirubicin—sarcoma	0.000451	0.000795	CcSEcCtD
Atomoxetine—Diarrhoea—Doxorubicin—sarcoma	0.000449	0.000792	CcSEcCtD
Atomoxetine—Rash—Epirubicin—sarcoma	0.000448	0.000789	CcSEcCtD
Atomoxetine—Dermatitis—Epirubicin—sarcoma	0.000447	0.000788	CcSEcCtD
Atomoxetine—Headache—Epirubicin—sarcoma	0.000445	0.000784	CcSEcCtD
Atomoxetine—Dizziness—Doxorubicin—sarcoma	0.000434	0.000765	CcSEcCtD
Atomoxetine—Nausea—Epirubicin—sarcoma	0.000422	0.000743	CcSEcCtD
Atomoxetine—Vomiting—Doxorubicin—sarcoma	0.000418	0.000736	CcSEcCtD
Atomoxetine—Rash—Doxorubicin—sarcoma	0.000414	0.00073	CcSEcCtD
Atomoxetine—Dermatitis—Doxorubicin—sarcoma	0.000414	0.000729	CcSEcCtD
Atomoxetine—Headache—Doxorubicin—sarcoma	0.000411	0.000725	CcSEcCtD
Atomoxetine—Nausea—Doxorubicin—sarcoma	0.00039	0.000688	CcSEcCtD
